Metvix® – A New Treatment for Actinic Keratoses

Dr. Ebrahim is pleased to offer Metvix® as an alternative to surgery for the treatment of Actinic Keratoses (AK) and certain types of Basal Cell Carcinomas (BCC).  This is a light-sensitive drug that is combined with a Red light treatment to destroy cancer cells.

Metvix® comes in a cream containing methyl aminolevulinate, which is specifically absorbed into the altered skin cells of these lesions.  Metvix® causes porphyrins to accumulate and be absorbed selectively by the AK and BCC lesions. These porphyrins are light sensitive, so when the Metvix is illuminated and activated by the Red light source, it causes a chemical reaction in the skin cells that destroys the lesion.

If you have actinic keratoses or basal cell carcinomas, call Afterglow for your complimentary consultation with Dr. Ebrahim.

Leave a Reply

Fields marked with * are required.

Back to Top